PYXS Historical PE Ratio image   This PYXS PE ratio history page last updated 11/3/2022
PYXS Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/1/2022
1.69-0.85-3.40NA
Q2 2022
8/15/2022
2.79-0.79-3.16NA
Q1 2022
5/13/2022
2.02-0.97-3.88NA
Q4 2021
3/29/2022
4.88-0.57-2.28NA
Q3 2021
11/15/2021
12.06-8.96-35.84NA
PYXS PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/1/2022
1.69-0.85-3.18NA
Q2 2022
8/15/2022
2.79-0.79-11.29NA
Q1 2022
5/13/2022
2.02-0.97NANA
Q4 2021
3/29/2022
4.88-0.57NANA
Q3 2021
11/15/2021
12.06-8.96NANA
How should the PYXS historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Pyxis Oncology. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this PYXS Historical PE Ratio page.

What is the average historical PE for PYXS based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The PYXS historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for PYXS based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The PYXS historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the PYXS Historical PE Ratio information for Pyxis Oncology' stock. The average PYXS historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average PYXS historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this PYXS historical PE result, against the recent PE: when this page was posted on 11/2/2022, the most recent closing price for PYXS had been 1.60, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on PYXS or any other given stock, valuation analysis for PYXS can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Pyxis Oncology PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PYXS. Thanks for visiting, and the next time you need to research PYXS Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Funds Holding OWLT, INGR Historical Stock Prices, IPS Split History.

 

PYXS Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.